Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 44399
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Scott999

Send PM
Followers 2
Posts 3528
Boards Moderated 0
Alias Born 06/23/2017

FREE
PSTI REPORT

Scott999

Re: FDApproved post# 44208

Tuesday, 01/24/2023 10:49:46 AM

Tuesday, January 24, 2023 10:49:46 AM

Post# of 44399
A tweet pre and post show. Talk about getting the bang for the buck. That marketing department they’ve had for years is truly earning their keep. They should branch off to other trade shows. Like magic or clowns. Just sayin.
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news
Only $200 per official company press release!